Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023 16:15 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
September 20, 2023 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of...
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
September 14, 2023 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis...
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023 16:10 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
August 28, 2023 05:30 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the appointment of Philippe Busque, Ph.D. as...
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
August 10, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences Reports Second Quarter 2023 Financial Results
August 08, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30,...
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
July 20, 2023 17:26 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second...
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
May 31, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming...
Cytek Biosciences Announces $50 Million Stock Repurchase Program
May 19, 2023 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the...